Prediction of kinetics of doxorubicin release from sulfopropyl dextran ion-exchange microspheres using artificial neural networks

被引:29
作者
Li, YQ
Rauth, AM
Wu, XY [1 ]
机构
[1] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON M5S 2S2, Canada
[2] Ontario Canc Inst, Toronto, ON M5G 2M9, Canada
基金
加拿大健康研究院;
关键词
artificial neural networks; prediction; release kinetics; doxorubicin; ion exchange microspheres;
D O I
10.1016/j.ejps.2004.12.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this work was to develop artificial neural networks (ANN) models to predict in vitro release kinetics of doxorubicin (Dox) delivered by sulfopropyl dextran ion-exchange microspheres. Four ANN models for responses at different time points were developed to describe the release profiles of Dox. Model selection was performed using the Akaike information criterion (AIC). Sixteen data sets were used to train the ANN models and two data sets for the validation. Good correlations were obtained between the observed and predicted release profiles for the two randomly selected validation data sets. The difference factor (f(1)) and similarity factor (f(2)) between the ANN predicted and the observed release profiles indicated good performance of the ANN models. The established models were then applied to predict release kinetics of Dox from the microspheres of various initial loadings in media of different ionic strengths and NaCl/CaCl2 ratios. The results suggested that ANN offered a flexible and effective approach to predicting the kinetics of Dox release from the ion-exchange microspheres. (C) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:401 / 410
页数:10
相关论文
共 47 条
[1]  
ABDEKHODAIE M, UNPUB DRUG LOADING O
[2]   ARTIFICIAL NEURAL NETWORKS - IMPLICATIONS FOR PHARMACEUTICAL SCIENCES [J].
ACHANTA, AS ;
KOWALSKI, JG ;
RHODES, CT .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1995, 21 (01) :119-155
[3]   Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research [J].
Agatonovic-Kustrin, S ;
Beresford, R .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2000, 22 (05) :717-727
[4]   NEW LOOK AT STATISTICAL-MODEL IDENTIFICATION [J].
AKAIKE, H .
IEEE TRANSACTIONS ON AUTOMATIC CONTROL, 1974, AC19 (06) :716-723
[5]  
Bourquin J, 1997, Pharm Dev Technol, V2, P111, DOI 10.3109/10837459709022616
[6]   Advantages of Artificial Neural Networks (ANNs) as alternative modelling technique for data sets showing non-linear relationships using data from a galenical study on a solid dosage form [J].
Bourquin, J ;
Schmidli, H ;
van Hoogevest, P ;
Leuenberger, H .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 7 (01) :5-16
[7]  
Bozic DZ, 1997, EUR J PHARM SCI, V5, P163
[8]  
CARPENTER WC, 1995, AI EXPERT MAR, P31
[9]  
CARTWRIGHT HM, 1993, APPL ARTIF INTELL, P13
[10]   Comparison of four artificial neural network software programs used to predict the in vitro dissolution of controlled-release tablets [J].
Chen, YX ;
Jiao, TJ ;
McCall, TW ;
Baichwal, AR ;
Meyer, MC .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2002, 7 (03) :373-379